London Daily

Focus on the big picture.
Monday, Jun 23, 2025

AstraZeneca Cancels £450 Million Vaccine Plant Expansion in Liverpool

AstraZeneca Cancels £450 Million Vaccine Plant Expansion in Liverpool

Company expresses disappointment over inability to secure government support for investment decision.
AstraZeneca's Chief Executive Officer, Pascal Soriot, has articulated his disappointment regarding the pharmaceutical company's decision to abandon a £450 million expansion project at its vaccine plant in Speke, Liverpool.

In statements made to the media on Thursday, Soriot noted that the company was unable to establish a viable business case for the investment, despite previous agreements with the government under the prior Conservative administration which included commitments of £90 million in grants and various forms of aid.

Soriot explained, "This is one of those cases...

where we could not make the business case work...

we needed a certain level of support to make this economically viable.

And that was not possible for the government to justify, which we totally understand.

On our side, we cannot justify this either.

We were all very disappointed, but that’s business life."

The decline of the project has stirred reactions from government officials.

Chris Bryant, the Science Minister, remarked that the difference in government offer and AstraZeneca's expectations was "remarkably small," labeling the company's decision as "deeply disappointing."

On the matter of funding, Soriot confirmed that the company initially aimed to increase its investment in the Speke facility to over £500 million.

He rejected suggestions of tension between AstraZeneca and the UK government, emphasizing the competitive nature of the pharmaceutical industry.

He pointed to the substantial support received from Singapore, where AstraZeneca is in the process of building a $1.5 billion site for antibody drug conjugates.

Additionally, Soriot urged UK officials to enhance efforts to draw in further investment, suggesting that changes to the drug rebate scheme — which requires pharmaceutical companies to return a percentage of their sales to the National Health Service — would not favor such investment initiatives.

In a separate context, AstraZeneca has reported a 21% rise in annual revenues to $54.1 billion in 2024, with pre-tax profits increasing by 38% to $8.7 billion on a constant currency basis.

This financial performance coincided with a rise in the company's shares by 5.7%, helping to lift the FTSE 100 index past 8,700 points to a new intraday high.

Moreover, AstraZeneca has provided insight into an ongoing investigation in China, where Leon Wang, president of the company’s operations there, along with other executives, has been detained due to allegations of illegally importing cancer medications.

The company disclosed that this case involves suspected unpaid importation taxes of $900,000, potentially leading to fines that could be fivefold the original amount if liability is established.

Soriot remarked on his wish for the detained executives and confirmed the appointment of Iskra Reic as Wang’s replacement.

Additionally, AstraZeneca faces scrutiny over an independent investigation related to medical insurance fraud in China.

In terms of its product portfolio, AstraZeneca's sales in cancer and respiratory medicine grew significantly, with revenues increasing by 24% and 25%, respectively, in the past year.

However, the company has projected a slowdown in overall sales growth for the upcoming fiscal year to a high single-digit percentage and reiterated its longer-term revenue goal of $80 billion by 2031, with expectations for late-stage results from seven new medicines this year.
Newsletter

Related Articles

0:00
0:00
Close
Starmer Invites Innovators to Join Government Talent Scheme
UK Economy’s Strong Opening Quarter Shows Signs of Cooling
Harrods Seeks Court Order to Secure Al Fayed Estate for Victims
BA and Singapore Airlines Cancel Dubai Flights Amid Middle East Tensions
Trump Faces Backlash from MAGA Base Over Iran Strikes
Meta Bets $14 B on Alexandr Wang to Drive AI Ambitions
WATCH: Israeli forces show the aftermath of a massive airstrike at Iran's Isfahan nuclear site
FedEx Founder Fred Smith, ‘Heart and Soul’ of the Company, Dies at 80
Chinese Factories Shift Away from U.S. Amid Trump‑Era Tariffs
Pimco Seizes Opportunity in Japan’s Dislocated Bond Market
Labubu Doll Drives Pop Mart to Status as China’s Most Valuable Toy Maker
Global Coal Demand Defies Paris Accord Goals
We have new information and breaking details to share about what is shaping up to be a historic air campaign tonight
Six Massive Bombs Dropped on Fordow; Trump: 'A Historic Moment for the U.S., Israel, and the World'
Fordow: Deeply Buried Iranian Enrichment Site in U.S.–Israel Crosshairs
United States Conducts Precision Strikes on Iran’s Nuclear Sites
US strikes Iran nuclear sites, Trump says
Pakistan to nominate Trump for Nobel Peace Prize.
BBC Demands Perplexity AI Immediately Stop Using Its Content
Telegram Founder: I Will Leave My Fortune to Over 100 of My Children
Political Turmoil Resurfaces in Belgium Amid Economic Concerns
Fed policymakers divided on timing of interest rate cuts
Trump signals imminent agreement with Harvard University
Inheritance tax referendum alarms Swiss billionaire community
Japan cancels bilateral security meeting amid US defence demands
AI skeptic Emily Bender warns that ‘the emperor has no clothes’
Israel Confirms Assassination of Quds Force Commander in Tehran
16 Billion Login Credentials Leaked in Unprecedented Cybersecurity Breach
Senate hearing on who was 'really running' Biden White House kicks off
Iranian Military Officers Reportedly Seek Contact with Reza Pahlavi, Signal Intent to Defect
FBI and Senate Investigate Allegations of Chinese Plot to Influence the 2020 Election in Biden’s Favor Using Fake U.S. Driver’s Licenses
Vietnam Emerges as Luxury Yacht Destination for Ultra‑Rich
Plans to Sell Dutch Embassy in Bangkok Face Local Opposition
China's Iranian Oil Imports Face Disruption Amid Escalating Middle East Tensions
Trump's $5 Million 'Trump Card' Visa Program Draws Nearly 70,000 Applicants
DGCA Finds No Major Safety Concerns in Air India's Boeing 787 Fleet
Airlines Reroute Flights Amid Expanding Middle East Conflict Zones
Elon Musk's xAI Seeks $9.3 Billion in Funding Amid AI Expansion
Trump Demands Iran's Unconditional Surrender Amid Escalating Conflict
Israeli Airstrike Targets Iranian State TV in Central Tehran
President Trump is leaving the G7 summit early and has ordered the National Security Council to the Situation Room
Taiwan Imposes Export Ban on Chips to Huawei and SMIC
Israel has just announced plans to strike Tehran again, and in response, Trump has urged people to evacuate
Netanyahu Signals Potential Regime Change in Iran
Juncker Criticizes EU Inaction on Trump Tariffs
EU Proposes Ban on New Russian Gas Contracts
Analysts Warn Iran May Resort to Unconventional Warfare
Iranian Regime Faces Existential Threat Amid Conflict
Energy Infrastructure Becomes War Zone in Middle East
UK Home Secretary Apologizes Over Child Grooming Failures
×